CollPlant Biotechnologies Ltd
(NASDAQ: CLGN)

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

1.906 -

-0.024 (-1.24%)
Range 1.880 - 1.950   (3.72%)
Open 1.880
Previous Close 1.930
Bid Price 1.850
Bid Volume 27
Ask Price 2.000
Ask Volume 180
Volume 7,104
Value 11,494
Remark -
Delayed prices. Updated at 30 Jan 2026 06:10.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis